Additional Information
Book Details
Abstract
This online Clinics series provides evidence-based answers to clinical questions that practicing hospitalists face daily. This issue of Hospital Medicine Clinics is Guest Editored by Dr. Steven Deitelzweig. Dr. Deitelzweig has assembled a group of expert authors to review the following topics: Bradyarrhythmias; Acute Respiratory Distress Syndrome; Tick Associated Ailments; Magnesium Disorders; Inpatient Management of Post- hepatic Transplant; Allergic Reactions and Angioedema; Optimal Glycemic Control in Hospitalized Patients; Ethics of Physician Relationships with Industry; Management of Benzodiazepine Withdrawal and Intoxication; and LEAN / Sig Sigma with Applicability to Healthcare.
Table of Contents
| Section Title | Page | Action | Price |
|---|---|---|---|
| Front Cover | Cover | ||
| Contributors | A1 | ||
| CONSULTING EDITOR | A1 | ||
| EDITOR | A1 | ||
| AUTHORS | A1 | ||
| Contents | A3 | ||
| Foreword | A3 | ||
| Preface | A3 | ||
| Inpatient Management of Patients After Liver Transplantation | A3 | ||
| Optimal Glycemic Control in Hospitalized Patients | A3 | ||
| Tick-borne Infections | A3 | ||
| Acute Respiratory Distress Syndrome | A4 | ||
| Benzodiazepine Intoxication and Withdrawal: Assessment and Management | A4 | ||
| Emergency Department Evaluation and Management of Bradyarrhythmia | A4 | ||
| Allergic Reactions and Angioedema | A4 | ||
| Magnesium Disorders | A5 | ||
| Ethics of Physician Relationships with Industry | A5 | ||
| Lean Hospital(ist)s | A5 | ||
| HOSPITAL MEDICINE CLINICS | A6 | ||
| FORTHCOMING ISSUES | A6 | ||
| January 2016 | A6 | ||
| April 2016 | A6 | ||
| July 2016 | A6 | ||
| RECENT ISSUES | A6 | ||
| July 2015 | A6 | ||
| April 2015 | A6 | ||
| January 2015 | A6 | ||
| Foreword | A7 | ||
| Preface | A8 | ||
| Inpatient Management of Patients After Liver Transplantation | 457 | ||
| EPIDEMIOLOGY | 458 | ||
| COMPLICATIONS, DIAGNOSIS, MANAGEMENT | 458 | ||
| Vascular Complications | 461 | ||
| Biliary Complications | 462 | ||
| Renal Injury | 463 | ||
| Infectious Complications | 463 | ||
| Posttransplantation Ascites | 466 | ||
| REJECTION | 466 | ||
| IMMUNOSUPPRESSION | 467 | ||
| RECURRENT DISEASE | 468 | ||
| CLINICAL GUIDELINE | 469 | ||
| REFERENCES | 469 | ||
| Optimal Glycemic Control in Hospitalized Patients | 471 | ||
| DEFINITIONS | 472 | ||
| MANAGEMENT GOALS | 473 | ||
| PHARMACOLOGIC STRATEGIES | 477 | ||
| Chronic Kidney Disease/End-Stage Renal Disease | 483 | ||
| Chronic Liver Disease | 484 | ||
| Hyperglycemic Emergencies and Critical Illness | 484 | ||
| Glucocorticoid Therapy | 484 | ||
| Enteral and Parenteral Nutrition | 485 | ||
| PERFORMANCE IMPROVEMENT | 485 | ||
| CLINICAL GUIDELINES | 486 | ||
| REFERENCES | 486 | ||
| Tick-borne Infections | 489 | ||
| DEFINITIONS | 490 | ||
| EPIDEMIOLOGY | 491 | ||
| HISTORY AND EXAMINATION | 491 | ||
| DIAGNOSIS | 494 | ||
| MANAGEMENT | 495 | ||
| CLINICAL GUIDELINES | 496 | ||
| PERFORMANCE IMPROVEMENT | 496 | ||
| REFERENCES | 499 | ||
| Acute Respiratory Distress Syndrome | 500 | ||
| RECOGNITION | 501 | ||
| CLINICAL COURSE AND PATHOPHYSIOLOGY OF ACUTE RESPIRATORY DISTRESS SYNDROME | 503 | ||
| MANAGEMENT PRINCIPLES | 504 | ||
| LOW TIDAL VOLUME VENTILATION | 505 | ||
| PRONE VENTILATION | 506 | ||
| REFRACTORY HYPOXEMIA | 507 | ||
| FLUID MANAGEMENT | 508 | ||
| WEANING FROM THE VENTILATOR | 508 | ||
| PROGNOSIS | 508 | ||
| PERFORMANCE IMPROVEMENT | 511 | ||
| CLINICAL GUIDELINES | 511 | ||
| REFERENCES | 511 | ||
| Benzodiazepine Intoxication and Withdrawal | 513 | ||
| OVERVIEW | 514 | ||
| PHARMACOLOGY | 514 | ||
| INTOXICATION | 515 | ||
| WITHDRAWAL | 518 | ||
| PERFORMANCE IMPROVEMENT | 524 | ||
| CLINICAL GUIDELINES | 524 | ||
| REFERENCES | 524 | ||
| Emergency Department Evaluation and Management of Bradyarrhythmia | 526 | ||
| DEFINITIONS | 526 | ||
| INITIAL APPROACH | 528 | ||
| TYPES OF RHYTHMS | 529 | ||
| INDUCED RHYTHMS | 534 | ||
| MANAGEMENT | 536 | ||
| CLINICAL GUIDELINES | 537 | ||
| PERFORMANCE IMPROVEMENT | 537 | ||
| REFERENCES | 538 | ||
| Allergic Reactions and Angioedema | 540 | ||
| DEFINITIONS | 541 | ||
| EPIDEMIOLOGY | 541 | ||
| HISTORY AND EXAMINATION | 542 | ||
| DIAGNOSIS | 542 | ||
| MANAGEMENT | 545 | ||
| PROGNOSIS | 547 | ||
| PERFORMANCE IMPROVEMENT | 547 | ||
| CLINICAL GUIDELINES | 548 | ||
| REFERENCES | 548 | ||
| Magnesium Disorders | 549 | ||
| MAGNESIUM HOMEOSTASIS AND DISORDERS | 550 | ||
| Magnesium Metabolism | 550 | ||
| Magnesium Intake | 551 | ||
| Magnesium Concentration | 551 | ||
| Regulating Magnesium Concentration | 553 | ||
| Assessing Magnesium Balance | 554 | ||
| MAGNESIUM DEFICIENCY AND HYPOMAGNESEMIA | 554 | ||
| Magnesium and Its Effects on Other Pathways in the Body | 554 | ||
| Proton-Pump Inhibitors and Hypomagnesemia | 556 | ||
| Signs and Symptoms of Magnesium Deficiency | 556 | ||
| Coexisting Electrolyte Disturbances | 556 | ||
| Hypomagnesemia and Cardiovascular Manifestations | 558 | ||
| Treatment | 560 | ||
| HYPERMAGNESEMIA | 560 | ||
| Causes of Hypermagnesemia | 560 | ||
| Clinical Manifestations of Hypermagnesemia | 560 | ||
| Serum Magnesium Level at Which Signs and Symptoms Occur | 561 | ||
| Neurologic Manifestations | 561 | ||
| Cardiovascular Manifestations | 561 | ||
| Treatment of Hypermagnesemia | 563 | ||
| PERFORMANCE IMPROVEMENT | 563 | ||
| CLINICAL GUIDELINES | 563 | ||
| REFERENCES | 563 | ||
| Ethics of Physician Relationships with Industry | 565 | ||
| KEY PRINCIPLES | 566 | ||
| GUIDELINES FOR PRACTICE | 571 | ||
| REFERENCES | 579 | ||
| Lean Hospital(ist)s | 581 | ||
| KEY PRINCIPLES | 582 | ||
| Definitions | 582 | ||
| Management Goals | 583 | ||
| GUIDELINES FOR PRACTICE | 583 | ||
| SUMMARY | 592 | ||
| REFERENCES | 593 |